NCT00002502View on ClinicalTrials.gov

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1992

Primary Completion Date

May 31, 2000

Study Completion Date

May 31, 2000

Conditions
LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Interventions
DRUG

busulfan

DRUG

cyclophosphamide

DRUG

cytarabine

PROCEDURE

allogeneic bone marrow transplantation

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002502 - Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter